SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-319350
Filing Date
2021-11-04
Accepted
2021-11-04 07:50:11
Documents
13
Period of Report
2021-11-04
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K d242780d8k.htm   iXBRL 8-K 26405
  Complete submission text file 0001193125-21-319350.txt   191426

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA tmb-20211104.xsd EX-101.SCH 3964
3 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE tmb-20211104_def.xml EX-101.DEF 14268
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE tmb-20211104_lab.xml EX-101.LAB 23648
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE tmb-20211104_pre.xml EX-101.PRE 15301
6 EXTRACTED XBRL INSTANCE DOCUMENT d242780d8k_htm.xml XML 6660
Mailing Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608
Business Address 2200 POWELL STREET SUITE 310 EMERYVILLE CA 94608 510-204-7239
XOMA Corp (Filer) CIK: 0000791908 (see all company filings)

IRS No.: 522154066 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39801 | Film No.: 211378060
SIC: 2834 Pharmaceutical Preparations